Objective: To examine preferences for treatments and health states for patients with
relapsing-remitting MS and members of the community. Methods: A survey was developed …

Background: The growing number of treatments for relapsing multiple sclerosis (MS)
provides opportunities to consider patient preferences in treatment decisions. Methods: We …

Abstract Background and Objective Patients' perceptions and experiences of medication
efficacy, medication adverse events, dosing frequency, and dosing complexity have been …

Objective: The aim of this study is to estimate the willingness of multiple sclerosis (MS)
patients to accept life-threatening adverse event risks in exchange for improvements in their …

Background While disease-modifying therapies (DMTs) for multiple sclerosis (MS)
treatments are costly, patient valuation of DMTs has not been examined. The objective of …

Objective: Although the effectiveness and risks of multiple sclerosis (MS) therapies are
established, relatively little is known about how these benefits and risks are perceived and …

Background A major debate in the quality-adjusted life-year (QALY) literature concerns
whose preferences should be used to estimate health state values (HSVs) and to calculate …

BACKGROUND: Treatment adherence in patients with multiple sclerosis (MS) is essential to
reduce the rate of acute neurological attacks, severity of relapses, and hospitalizations and …

Purpose The aim of this study was to estimate preferences related to quality of life attributes
in people with multiple sclerosis, by keeping heterogeneity of patient preference in mind …

Objectives: To (i) quantify the cost of multiple sclerosis (MS) to the Canadian health care
system and society;(ii) measure health utility in MS patients, and (iii) examine the influence …